Veru to Proceed With Late-Stage Study of COVID Pill Despite FDA Snub
The drug developer said it plans to proceed with a late-stage trial of its COVID-19 pill, weeks after the FDA declined to authorize the oral drug to treat high-risk patients hospitalized with COVID-19.
Reuters Health Information
source https://www.medscape.com/viewarticle/989635?src=rss
Reuters Health Information
source https://www.medscape.com/viewarticle/989635?src=rss
Comments
Post a Comment